F.D.A. Rejects Savient’s Gout Drug

Monday, August 3, 2009 - 09:56 in Health & Medicine

The maker of Krystexxa said regulators were concerned about changes to the manufacturing process.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net